Novo Nordisk A/S (NVO)
38.62
+0.45
(+1.18%)
USD |
NYSE |
Sep 24, 16:00
38.61
-0.01
(-0.03%)
After-Hours: 19:59
Novo Nordisk Gross Profit (Annual) : 37.55B for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 37.55B |
| December 31, 2024 | 35.31B |
| December 31, 2023 | 28.07B |
| December 31, 2022 | 20.62B |
| December 31, 2021 | 18.36B |
| December 31, 2020 | 15.88B |
| December 31, 2019 | 15.12B |
| December 31, 2018 | 14.71B |
| December 31, 2017 | 14.17B |
| December 31, 2016 | 13.98B |
| December 31, 2015 | 13.57B |
| December 31, 2014 | 13.11B |
| December 31, 2013 | 12.26B |
| December 31, 2012 | 11.04B |
| December 31, 2011 | 9.921B |
| December 31, 2010 | 8.623B |
| December 31, 2009 | 7.504B |
| December 31, 2008 | 6.888B |
| December 31, 2007 | 5.808B |
| December 31, 2006 | 4.859B |
| December 31, 2005 | 4.059B |
| December 31, 2004 | 3.512B |
| December 31, 2003 | 2.851B |
| Date | Value |
|---|---|
| December 31, 2002 | 2.301B |
| December 31, 2001 | 2.097B |
| December 31, 2000 | 1.902B |
| December 31, 1999 | 2.001B |
| December 31, 1998 | 1.714B |
| December 31, 1997 | 1.615B |
| December 31, 1996 | 1.599B |
| December 31, 1995 | 1.498B |
| December 31, 1994 | 1.285B |
| December 31, 1993 | 540.32M |
| December 31, 1992 | 521.66M |
| December 31, 1991 | 421.71M |
| December 31, 1990 | 334.68M |
| December 31, 1989 | 257.72M |
| December 31, 1988 | 204.00M |
| December 31, 1987 | 72.79M |
| December 31, 1986 | 76.29M |
| December 31, 1985 | 64.53M |
| December 31, 1984 | 75.56M |
| December 31, 1983 | 92.09M |
| December 31, 1982 | 67.54M |
| December 31, 1981 | 67.59M |
| December 31, 1980 | 53.69M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| AstraZeneca PLC | 43.95B |
| GSK Plc | 30.76B |
| Johnson & Johnson | 64.63B |
| Eli Lilly & Co. | 54.13B |
| Merck & Co., Inc. | 46.73B |